Interscalene brachial plexus anesthesia and analgesia for open shoulder surgery: A randomized, double-blinded comparison between levobupivacaine and ropivacaine

Anesthesia and Analgesia

Volumn 96, Issue 1, 2003, Pages 253-259

  Casati, Andrea ^a   Borghi, Battista ^b   Fanelli, Guido ^c   Montone, Nicoletta ^b   Rotini, Roberto ^b   Fraschini, Gianfranco ^a   Vinciguerra, Federico ^a   Torri, Giorgio ^a   Chelly, Jacques ^d  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; LEVOBUPIVACAINE; ROPIVACAINE;

ADULT; AGED; ANALGESIA; ANESTHESIA INDUCTION; ARTICLE; BRACHIAL PLEXUS; BRACHIAL PLEXUS ANESTHESIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG USE; FEMALE; HUMAN; INFUSION; INJECTION; INTRAOPERATIVE PERIOD; MALE; MOTOR PERFORMANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SHOULDER; TIME; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; AMIDES; ANESTHETICS, LOCAL; BRACHIAL PLEXUS; BUPIVACAINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE BLOCK; ORTHOPEDIC PROCEDURES; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATIENT SATISFACTION; SAMPLE SIZE; SHOULDER;

EID: 0037219185     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200301000-00051     Document Type: Article

References (24)

1. Foster RH, Markham A. Levobupivacaine: A review of its pharmacology and use as a local anaesthetic. Drugs 2000;59:551-79.
2. Mazoit J, Boico O, Samii K. Myocardial uptake of bupivacaine. II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993;77:907-82.
3. Cox CR, Checketts MR, MacKenzie N, et al. Comparison of S(-)bupivacaine with racemic (RS)-bupivacaine in supraclavicular brachial plexus block. Br J Anaesth 1998;80:594-8.
4. Chelly JE, Casati A, Fanelli G, eds. Continuous Peripheral Nerve Block Techniques: An Illustrated Guide. Segrate, Italy: Mosby, 2001:3-23.
5. Borgeat A, Schappi B, Biasca N, Gerber C. Patient-controlled analgesia after major shoulder surgery: Patient-controlled interscalene analgesia versus patient-controlled analgesia. Anesthesiology 1997;87:1343-7.
6. Pere P, Pitkanen M, Rosenberg PH, et al. Effects of continuous interscalene brachial plexus block on diaphragm motion and on ventilatory function. Acta Anaesthesiol Scand 1992;36:53-7.
7. Borgeat A, Perschak H, Bird P, et al. Patient-controlled interscalene analgesia with ropivacaine 0.2% versus patient-controlled intravenous analgesia after major shoulder surgery: Effects on diaphragmatic and respiratory function. Anesthesiology 2000;92:102-8.
8. Alemanno F, Bertini L, Casati A, di Benedetto P. Brachial plexus. In: Chelly JE, Casati A, Fanelli G, eds. Continuous Peripheral Nerve Block Techniques: An Illustrated Guide. Segrate, Italy: Mosby, 2001:47-58.
9. Casati A, Fanelli G, Albertin A, et al. Interscalene brachial plexus anesthesia with either 0.5% ropivacaine or 0.5% bupivacaine. Minerva Anestesiol 2000;66:39-44.
10. Browner WS, Black D, Newman B, Hulley SB. Estimating sample size and power. In: Hulley SB, Cummings SR, eds. Designing Clinical Research: An Epidemiologic Approach. Baltimore: Williams & Wilkins, 1988:139-50.
11. Glaser C, Marhofer P, Zimpfer G, et al. Levobupivacaine versus racemic bupivacaine for spinal anesthesia. Anesth Analg 2002; 94:194-8.
12. Kopacz DJ, Allen HW, Thompson GE. A comparison of epidural levobupivacaine 0.75% with racemic bupivacaine for lower abdominal surgery. Anesth Analg 2000;90:642-8.
13. Casati A, Chelly JE, Cerchierini E, et al. Clinical properties of levobupivacaine or racemic bupivacaine for sciatic nerve block. J Clin Anesth 2002;14:111-4.
14. Santorsola R, Casati A, Cerchierini E, et al. Levobupivacaine for peripheral blocks of the lower limb: A clinical comparison with bupivacaine and ropivacaine. Minerva Anestesiol 2001; 67:33-6.
15. Casati A, Fanelli G, Cedrati V, et al. Pulmonary function changes after interscalene brachial plexus anesthesia with 0.5% and 0.75% ropivacaine: A double-blind comparison with 2% mepivacaine. Anesth Analg 1999;88:587-92.
16. Lyons G, Columb M, Wilson RC, Johnson RV. Epidural pain relief in labour: Potencies of levobupivacaine and racemic bupivacaine. Br J Anaesth 1998;81:899-901.
17. Polley LS, Columb MO, Naughton NN, et al. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor. Anesthesiology 1999;90:944-50.
18. Borgeat A, Kalberer F, Jacob H, et al. Patient-controlled interscalene analgesia with ropivacaine 0.2% versus bupivacaine 0.15% after major open shoulder surgery: The effects on hand and motor function. Anesth Analg 2001;92:218-23.
19. Casati A, Borghi B, Fanelli G, et al. A double-blind, randomized comparison of either 0.5% levobupivacaine or 0.5% ropivacaine for sciatic nerve block. Anesth Analg 2002;94:987-90.
20. Dony P, Dewinde V, Vanderick B, et al. The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats. Anesth Analg 2000;91:1489-92.
21. Tuominen M, Haasio J, Hekali R, Rosenberg PH. Continuous interscalene brachial plexus block: Clinical efficacy, technical problems and bupivacaine plasma concentrations. Acta Anaesthesiol Scand 1989;33:84-8.
22. Huang YF, Pryor ME, Mather LE, et al. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998;86:797-804.
23. Denson DD, Behbehani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992;17:311-6.
24. Bardsley H, Gristwood R, Baker H, et al. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1998;46:245-9.